All stocks Β· SAKAR
SH

Sakar Healthcare Limited

SAKAR NSE Drug Manufacturers - Specialty & Generic Healthcare

Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injecta…

ISIN INE732S01012
Listed 11 Apr 2019
Quarters tracked 13
Filings 13 docs

About

Sakar Healthcare Limited research, develops, manufactures, and sells pharmaceutical products in India. The company provides liquid orals, cephalosporin tablets, capsules, dry powder syrups and injections, liquid injectable (SVP) in ampoules, vials and lyophilized injections, and oral solid dosages. Its product portfolio consists of formulations in therapeutic areas, such as anti-infective, analgesic, antihistamine, anthelmintic, anti-malarial, antibacterial, vitamins, antifungal, diuretics, oxytocic, antacid, laxative, anticoagulant, anaesthetic, bronchodilator, adrenergic, sedative, anti-inflammatory, antiemetic, anticonvulsant, antipsychotic, antidepressant, and anti-cancer. The company exports its products to Southeast Asia, Asia, Africa-Anglo and Francophone, MENA countries, and the United States. Sakar Healthcare Limited was incorporated in 2004 and is based in Ahmedabad, India.

Key Metrics

as of Sep 2026
Market Cap2,256 Cr
P/E62.50
Div Yield0.00 %
Book Valueβ‚Ή146.00
52w Highβ‚Ή1,024.00
52w Lowβ‚Ή321.00
Face Valueβ‚Ή10.00

Quarterly Results

Rs. Crores Β· hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 73.00 71.00 70.00 58.00 53.00 50.00 43.00 43.00 41.00 43.00 37.00 34.00 39.00
Expenses 52.00 45.00 52.00 46.00 40.00 35.00 32.00 31.00 30.00 32.00 28.00 25.00 30.00
Operating Profit 21.00 26.00 19.00 11.00 13.00 16.00 12.00 12.00 11.00 11.00 9.00 9.00 9.00
OPM % 29.00 37.00 26.00 20.00 24.00 31.00 27.00 27.00 26.00 25.00 24.00 27.00 23.00
Other Income 2.00 0.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 1.00 0.00 1.00 2.00
Depreciation 7.00 6.00 6.00 6.00 6.00 5.00 5.00 5.00 5.00 5.00 4.00 4.00 5.00
Interest 2.00 2.00 2.00 2.00 2.00 4.00 1.00 2.00 1.00 2.00 2.00 2.00 2.00
Profit before tax 15.00 18.00 11.00 5.00 5.00 6.00 5.00 5.00 5.00 5.00 3.00 4.00 4.00
Tax % 29.00 39.00 6.00 15.00 13.00 8.00 17.00 6.00 49.00 35.00 31.00 13.00 28.00
Net Profit 10.00 11.00 10.00 5.00 5.00 6.00 5.00 5.00 2.00 3.00 2.00 4.00 3.00
EPS in Rs 4.62 4.95 4.61 2.04 2.10 2.62 2.06 2.21 1.11 1.43 0.95 1.70 1.49

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Sales 251.00178.00153.00133.00128.0095.0083.00
Expenses 182.00128.00115.00100.0099.0072.0063.00
Operating Profit 69.0050.0038.0033.0029.0023.0020.00
OPM % 27.0028.0025.0025.0023.0024.0024.00
Other Income 2.001.003.005.002.001.002.00
Interest 8.009.008.006.003.002.002.00
Depreciation 24.0021.0018.0015.0010.008.007.00
Profit before tax 40.0022.0016.0017.0019.0013.0012.00
Tax % 23.0019.0027.0024.0020.0019.0021.00
Net Profit 30.0018.0012.0013.0015.0011.0010.00
EPS in Rs 13.707.975.376.708.906.846.43
Dividend Payout % 0.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Equity Capital 22.0022.0022.0019.0017.0016.0015.00
Reserves 302.00264.00241.00154.00110.0083.0066.00
Borrowings 71.0086.0079.00119.0093.0043.0017.00
Other Liabilities 86.0043.0047.0044.0047.0037.0017.00
Total Liabilities 481.00415.00389.00336.00268.00178.00115.00
Fixed Assets 326.00309.00314.00267.00205.0069.0066.00
CWIP 4.0017.000.006.001.0049.0013.00
Investments 0.000.000.003.007.000.000.00
Other Assets 151.0090.0074.0060.0055.0060.0036.00
Total Assets 481.00415.00389.00336.00268.00178.00115.00

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Cash from Operating Activity 49.0034.0024.0033.0036.0015.0019.00
Cash from Investing Activity -28.00-31.00-52.00-74.00-90.00-47.00-22.00
Cash from Financing Activity -21.00-3.0027.0041.0055.0032.003.00
Net Cash Flow 0.000.000.000.000.000.000.00
Free Cash Flow 21.002.00-35.00-49.00-62.00-32.00-4.00
CFO/OP % 77.0073.0072.00113.00120.0067.00110.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debtor Days 73.0063.0050.0060.0040.0048.0036.00
Inventory Days 207.00193.00121.0076.0069.00112.0092.00
Days Payable 153.0093.00120.00129.00149.00141.0046.00
Cash Conversion Cycle 127.00163.0051.007.00-39.0019.0083.00
Working Capital Days 45.0052.0029.00-6.00-11.001.0031.00
ROCE % 12.009.007.009.0012.0013.00β€”

Shareholding Pattern

% holding β€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 52.52 52.86 52.86 52.86 52.86 53.58 53.58 53.15 53.15 53.15 53.15 54.15
FIIs 12.13 12.94 13.05 13.31 13.41 13.61 13.58 13.42 13.52 13.52 13.76 14.03
DIIs 11.37 11.32 11.36 11.43 11.25 10.97 10.88 10.62 10.62 10.62 10.62 10.82
Public 23.98 22.87 22.73 22.41 22.48 21.85 21.96 22.80 22.71 22.71 22.47 21.00
No. of Shareholders 14,734 9,580 7,069 7,565 8,115 8,608 8,598 7,867 7,313 7,386 7,001 7,299

Corporate Actions

6 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Other 13 Sep 2024 β€” β€” β€” Annual General Meeting
Other 14 Sep 2023 β€” β€” β€” Annual General Meeting
Other 12 Sep 2022 β€” β€” β€” Annual General Meeting
Other 16 Sep 2021 β€” β€” β€” Annual General Meeting
Other 16 Sep 2020 β€” β€” β€” Annual General Meeting
Other 06 Sep 2019 β€” β€” β€” Annual General Meeting

Announcements

5 filings